These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
151 related articles for article (PubMed ID: 9555795)
1. Low-dose low-molecular-weight heparin (enoxaparin) is beneficial in lichen planus: a preliminary report. Hodak E; Yosipovitch G; David M; Ingber A; Chorev L; Lider O; Cahalon L; Cohen IR J Am Acad Dermatol; 1998 Apr; 38(4):564-8. PubMed ID: 9555795 [TBL] [Abstract][Full Text] [Related]
2. The management of lichen planus with low-molecular-weight heparin (enoxaparin). Akdeniz S; Harman M; Atmaca S; Yaldiz M Int J Clin Pract; 2005 Nov; 59(11):1268-71. PubMed ID: 16236078 [TBL] [Abstract][Full Text] [Related]
3. Low molecular weight heparin; a novel alternative therapeutic approach for lichen planus. Stefanidou MP; Ioannidou DJ; Panayiotides JG; Tosca AD Br J Dermatol; 1999 Dec; 141(6):1040-5. PubMed ID: 10606849 [TBL] [Abstract][Full Text] [Related]
4. Low-dose low-molecular-weight heparin in lichen planus. Rai R; Kaur I; Kumar B J Am Acad Dermatol; 2002 Jan; 46(1):141-3. PubMed ID: 11756963 [No Abstract] [Full Text] [Related]
5. Successful treatment of lichen planus with low-molecular-weight heparin: a case series of seven patients. Pacheco H; Kerdel F J Dermatolog Treat; 2001 Jun; 12(2):123-6. PubMed ID: 12243672 [TBL] [Abstract][Full Text] [Related]
6. Low-molecular-weight heparin (enoxaparin) in the treatment of lichen planus. Ferahbas A; Uksal U; Kutlugun C; Kontas O J Eur Acad Dermatol Venereol; 2003 Sep; 17(5):604-5. PubMed ID: 12941111 [No Abstract] [Full Text] [Related]
7. The successful treatment of palmoplantar hyperkeratotic lichen planus with enoxaparin. Yasar S; Serdar ZA; Goktay F; Doner N; Tanzer C; Akkaya D; Gunes P Indian J Dermatol Venereol Leprol; 2011; 77(1):64-6. PubMed ID: 21220884 [No Abstract] [Full Text] [Related]
8. Oral Lichen Planus Associated With Lichen Planus Pigmentosus and Lichen Sclerosus in Monozygotic Twins. Marques LC; Santos LR; da Silva NC; Cunha KS; Junior AS; Conde DC Am J Dermatopathol; 2021 May; 43(5):368-372. PubMed ID: 33395041 [TBL] [Abstract][Full Text] [Related]
9. Efficacy of oral low-dose tretinoin (all-trans-retinoic acid) in lichen planus. Ott F; Bollag W; Geiger JM Dermatology; 1996; 192(4):334-6. PubMed ID: 8864368 [TBL] [Abstract][Full Text] [Related]
10. Safety and efficacy of high-dose clobetasol propionate 0.05% in cutaneous lichen planus. Melin A; Bouchereau S; Guelimi R; Bergqvist C; Condamina M; Giraud-Kerleroux L; Hirsch G; Hua C; Wolkenstein P; Skayem C; Le Cleach L J Dermatol; 2023 Jun; 50(6):810-813. PubMed ID: 36578108 [TBL] [Abstract][Full Text] [Related]
11. The vulvovaginal-gingival syndrome of lichen planus. The clinical characteristics of 22 patients. Eisen D Arch Dermatol; 1994 Nov; 130(11):1379-82. PubMed ID: 7979437 [TBL] [Abstract][Full Text] [Related]
12. Oral, esophageal and cutaneous lichen ruber planus controlled with alitretinoin: case report and review of the literature. Kolios AG; Marques Maggio E; Gubler C; Cozzio A; Dummer R; French LE; Navarini AA Dermatology; 2013; 226(4):302-10. PubMed ID: 23948733 [TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of oral methotrexate versus oral mini pulse betamethasone therapy in the treatment of lichen planus: a comparative study. Gamal Alsakaan NA; Abd-Elsalam S; Fawzy MM; Elwan NM J Dermatolog Treat; 2022 Nov; 33(7):3039-3046. PubMed ID: 35856817 [TBL] [Abstract][Full Text] [Related]